Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.

Hagiya Y, Endo Y, Yonemura Y, Takahashi K, Ishizuka M, Abe F, Tanaka T, Okura I, Nakajima M, Ishikawa T, Ogura S.

Photodiagnosis Photodyn Ther. 2012 Sep;9(3):204-14. doi: 10.1016/j.pdpdt.2011.12.004.

PMID:
22959800
2.

Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.

Hagiya Y, Fukuhara H, Matsumoto K, Endo Y, Nakajima M, Tanaka T, Okura I, Kurabayashi A, Furihata M, Inoue K, Shuin T, Ogura S.

Photodiagnosis Photodyn Ther. 2013 Sep;10(3):288-95. doi: 10.1016/j.pdpdt.2013.02.001.

PMID:
23993855
3.

ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.

Palasuberniam P, Yang X, Kraus D, Jones P, Myers KA, Chen B.

Sci Rep. 2015 Aug 18;5:13298. doi: 10.1038/srep13298.

4.

Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.

Yamamoto M, Fujita H, Katase N, Inoue K, Nagatsuka H, Utsumi K, Sasaki J, Ohuchi H.

Acta Med Okayama. 2013;67(3):153-64.

5.

Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation.

Kobuchi H, Moriya K, Ogino T, Fujita H, Inoue K, Shuin T, Yasuda T, Utsumi K, Utsumi T.

PLoS One. 2012;7(11):e50082. doi: 10.1371/journal.pone.0050082.

6.

Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.

Ishikawa T, Kajimoto Y, Inoue Y, Ikegami Y, Kuroiwa T.

Adv Cancer Res. 2015;125:197-216. doi: 10.1016/bs.acr.2014.11.008. Review.

PMID:
25640271
7.

Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition.

Barron GA, Moseley H, Woods JA.

J Photochem Photobiol B. 2013 Sep 5;126:87-96. doi: 10.1016/j.jphotobiol.2013.07.003.

PMID:
23911860
8.

Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.

Ogino T, Kobuchi H, Munetomo K, Fujita H, Yamamoto M, Utsumi T, Inoue K, Shuin T, Sasaki J, Inoue M, Utsumi K.

Mol Cell Biochem. 2011 Dec;358(1-2):297-307. doi: 10.1007/s11010-011-0980-5.

PMID:
21748335
9.

Gefitinib enhances the efficacy of photodynamic therapy using 5-aminolevulinic acid in malignant brain tumor cells.

Sun W, Kajimoto Y, Inoue H, Miyatake S, Ishikawa T, Kuroiwa T.

Photodiagnosis Photodyn Ther. 2013 Feb;10(1):42-50. doi: 10.1016/j.pdpdt.2012.06.003.

PMID:
23465372
10.

Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells.

Chung CW, Kim CH, Lee HM, Kim DH, Kwak TW, Chung KD, Jeong YI, Kang DH.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):503-10. doi: 10.1016/j.ejpb.2013.01.022.

PMID:
23429232
11.

Effects of plasma membrane ABCB6 on 5-aminolevulinic acid (ALA)-induced porphyrin accumulation in vitro: tumor cell response to hypoxia.

Matsumoto K, Hagiya Y, Endo Y, Nakajima M, Ishizuka M, Tanaka T, Ogura S.

Photodiagnosis Photodyn Ther. 2015 Mar;12(1):45-51. doi: 10.1016/j.pdpdt.2014.12.008.

PMID:
25573285
12.

Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.

Suzuki T, Wada S, Eguchi H, Adachi J, Mishima K, Matsutani M, Nishikawa R, Nishiyama M.

J Neurosurg. 2013 Nov;119(5):1331-9. doi: 10.3171/2013.7.JNS122340.

PMID:
24010971
13.

The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.

Fukuhara H, Inoue K, Kurabayashi A, Furihata M, Fujita H, Utsumi K, Sasaki J, Shuin T.

Photodiagnosis Photodyn Ther. 2013 Dec;10(4):399-409. doi: 10.1016/j.pdpdt.2013.03.003.

PMID:
24284092
14.

Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.

Kim JH, Park JM, Roh YJ, Kim IW, Hasan T, Choi MG.

BMC Cancer. 2015 Jul 7;15:504. doi: 10.1186/s12885-015-1514-4.

15.

The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.

Liu W, Baer MR, Bowman MJ, Pera P, Zheng X, Morgan J, Pandey RA, Oseroff AR.

Clin Cancer Res. 2007 Apr 15;13(8):2463-70.

16.

ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.

Robey RW, Steadman K, Polgar O, Bates SE.

Cancer Biol Ther. 2005 Feb;4(2):187-94.

PMID:
15684613
17.

5-Aminolevulinic acid enhances cell death under thermal stress in certain cancer cell lines.

Chibazakura T, Toriyabe Y, Fujii H, Takahashi K, Kawakami M, Kuwamura H, Haga H, Ogura S, Abe F, Nakajima M, Yoshikawa H, Tanaka T.

Biosci Biotechnol Biochem. 2015;79(3):422-31. doi: 10.1080/09168451.2014.975186.

PMID:
25346276
18.

Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.

Nakanishi T, Ogawa T, Yanagihara C, Tamai I.

J Pharm Sci. 2015 Sep;104(9):3092-100. doi: 10.1002/jps.24462.

PMID:
25959076
19.

Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma.

Zhao SG, Chen XF, Wang LG, Yang G, Han DY, Teng L, Yang MC, Wang DY, Shi C, Liu YH, Zheng BJ, Shi CB, Gao X, Rainov NG.

Ann Surg Oncol. 2013 Dec;20(13):4379-88. doi: 10.1245/s10434-011-2201-6.

PMID:
22688660
20.

Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.

Ishikawa T, Kajimoto Y, Sun W, Nakagawa H, Inoue Y, Ikegami Y, Miyatake S, Kuroiwa T.

J Pharm Sci. 2013 Sep;102(9):3058-69. doi: 10.1002/jps.23563. Review.

PMID:
23650051
Items per page

Supplemental Content

Support Center